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Abstract
Criminal justice (CJ) settings disproportionately include populations at high risk for acquiring
HIV, and CJ-involved individuals are often at the intersection of multiple overlapping risk fac-
tors. However, few studies have examined attitudes about pre-exposure prophylaxis (PrEP)
among incarcerated men who have sex with men (MSM). This study explored interest in,
knowledge of, and barriers to PrEP uptake among gay, bisexual, and other men who have
sex with men at the Rhode Island Department of Corrections. Using semi-structured inter-
views, 26 MSM were interviewed about PrEP knowledge, interest, timing preferences for
provision (e.g. before or after release), and barriers to uptake and adherence during com-
munity re-entry. Interviews were coded and analyzed using a general inductive approach.
Participants demonstrated low initial knowledge of PrEP but high interest after being told
more about it. Participants self-identified risk factors for HIV acquisition, including condom-
less sex and substance use. In addition, participants preferred provision of PrEP prior to
release. Post-release barriers to PrEP uptake and adherence included 1) concerns about
costs of PrEP medications; 2) anticipated partner or family disapproval; 3) lack of access to
transportation; 4) unstable housing; 5) compounding impacts of multiple hardships leading
to a de-prioritization of PrEP and 6) fears of future re-incarceration. These results point to
the need for future PrEP interventions among incarcerated populations that address incar-
ceration and PrEP related barriers during community re-entry via wraparound services that
address PrEP and incarceration-related barriers.
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Background
Criminal-justice (CJ) involved populations in the United States (US) are at increased risk for
acquiring HIV. Rates of HIV among CJ-involved individuals are three times higher than in the
general population [1] and one in seven HIV positive people pass through a local jail in any
given year [1, 2]. Gay, bisexual, and other men who have sex with men (MSM) also have a
heightened risk of HIV acquisition, which could be further amplified by substance use and
other factors, including recent incarceration [3, 4]. The term “men who have sex with men”
(MSM) refers to a heterogeneous group of men who have sex with members of the same sex,
regardless of their sexual orientation. MSM who are CJ-involved are at increased risk for HIV
infection, particularly Black MSM [5, 6]. In a study of 1,278 MSM in six US cities, incarcera-
tion rates were high, with 49% of individuals under the age of 30 reporting ever being incarcer-
ated while 73% of those over 30 years reported ever being incarcerated [7]. For MSM, recent
incarceration may disrupt relationships and contribute to sexual concurrency, resulting in
higher HIV risk [8]. Some research has shown that HIV prevention programs implemented in
CJ settings can be effective (e.g. condom distribution programs) [9, 10]. However, little
research has focused on MSM who are currently incarcerated. Given that CJ-settings dispro-
portionately include populations at high risk for acquiring HIV, they could be important ven-
ues to engage MSM in HIV prevention efforts.
A novel strategy for addressing HIV risk among CJ-involved MSM is exploring the poten-
tial use of pre-exposure prophylaxis (PrEP) while individuals are incarcerated or as they are
preparing for release (with linkage to PrEP care in the community). PrEP is a bio-behavioral
HIV prevention intervention that consists of an antiretroviral medication (emtricitabine/teno-
fovir, FTC/TDF) taken orally on a daily basis by HIV-uninfected individuals. PrEP’s efficacy
has been well established in randomized controlled trials and open label studies [11–14]. The
Centers for Disease Control and Prevention recommend PrEP be considered for at-risk popu-
lations including MSM [15]. In addition, the World Health Organization has introduced the
concept of “substantive risk” as a precursor to PrEP indication. Those at substantive risk of
HIV include any individual belonging to a group that has a disproportionate burden of HIV,
which includes those with a history of incarceration and MSM [16].
A PrEP care continuum has been established that highlights the importance of PrEP aware-
ness, access, linkage to PrEP care, uptake, adherence, and retention in care [17], and PrEP effi-
cacy is closely tied to adherence [18]. Barriers to PrEP uptake are multi-level (individual,
social, and structural) and include low awareness and knowledge of PrEP, perceived side
effects, concerns about drug effectiveness, cost, access to PrEP prescriptions and medical care,
perceived HIV-risk, stigma, and medical mistrust [19–27]. However, the degree to which indi-
vidual, social, and structural barriers to PrEP uptake are exacerbated by incarceration and how
they interact to impede use of PrEP among MSM with CJ experience is largely unknown.
However, those with recent CJ-involvement often face substantial struggles during the post-
release period such as loss of social support, inability to find housing or employment, and
untreated mental illness or addiction [28, 29]. Our group has also found that medical and insti-
tutional distrust and lack of access to care may be barriers to engagement in HIV prevention
programs [30]. Due in part to these kinds of barriers, PrEP uptake in real world settings such
as CJ venues and after release remains low [31, 32].
In the current study, we interviewed 26 MSM who were incarcerated to explore PrEP
knowledge, interest in taking PrEP, and potential barriers to uptake and adherence both in the
correctional setting and the community. Given the lack of research that includes incarcerated
MSM, this unique perspective underscores the significance of this study. In addition, to our
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knowledge, this study is among the first to investigate PrEP use, uptake, and adherence among
incarcerated MSM.
Methods
This study was conducted at the Rhode Island Department of Corrections (RIDOC) in Cran-
ston, Rhode Island (RI). The RIDOC is a unified prison and jail through which approximately
15,000 men cycle each year [33]. The prevalence of HIV at the RIDOC is 3%, which mirrors
correctional estimates of HIV prevalence in other jail or prison settings [34]. While RIDOC
medical administration is interested in beginning a PrEP program, there is not yet one in
place.
During medical intake, all individuals are asked about whether they self-identify as gay,
straight, bisexual, or MSM by a RIDOC nurse. All individuals who reported being gay, bisex-
ual, or MSM were approached and informed about the study. All possible participants that
were approached had the ability to decline participation. Only one possible participant
declined to participate. Due to the sensitive nature of this research, we requested a waiver of
documentation of consent. This mean that participants only gave verbal consent prior to
beginning the interview and the research team collected no identifiable information.
In addition, to being gay, bisexual, or MSM, study criteria included being over the age of
18, self-reporting as HIV negative, and ability to read and speak English. Semi-structured
interviews lasted approximately 45–60 minutes and were conducted by trained qualitative
researchers (LBR, CL, and MP). Interview topics included HIV knowledge, HIV risk percep-
tions, PrEP knowledge, PrEP interest, barriers/facilitators to taking PrEP while incarcerated,
barriers/facilitators to taking PrEP in the community, and attitudes and suggestions about pos-
sible interventions. All interviews were conducted in a private room, digitally recorded and
later transcribed. For participation, individuals received $30 that was deposited into their com-
missary account. Recruitment from the study occurred from September 2016 through October
2017. This study was approved by the Miriam Hospital’s institutional review board. The
authors requested a waiver for documentation of consent. Therefore, all participants were
informed about the study and only gave verbal consent to participate.
A general inductive approach guided the analysis, which allowed for the data to be formu-
lated into themes and categories [35]. Coders (MP, LBR, and CL) read the transcribed data for
participant responses that were similar and looked for recurrent themes and patterns in the
transcripts. Open and axial coding were then used to outline concepts among two coders.
Each theme and sub-theme was then assigned a code, and the codes were compiled in a code-
book. Quality checks were conducted on 20% of all transcripts via iterative coding by at least
two coders. At the beginning of the coding process coders separately coded transcripts and
then went through each transcript to discuss discrepancies, consensus, and the creation of
new, relevant codes. Discrepancies in interpretation were resolved among the research team
before final coding commenced. Thematic saturation was achieved with the final sample.
Results
Of the 26 participants, 16 were white, 8 were black, and 2 were Hispanic. Participants ranged
in age from 23 to 57, and the average age was 38. None of the participants had ever been on
PrEP before or tried to obtain it in the community. Across all interviews, key themes emerged
related to 1) knowledge and interest in PrEP; 2) preferences for PrEP provision and 3) antici-
pated barriers to PrEP uptake and adherence during community re-entry.
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HIV risk and PrEP knowledge and interest
Many participants had never heard of PrEP, but some had limited knowledge about it. One
participant stated: “I know that it’s a pill and people take it. I have, there’s some friends I
know, acquaintances, that I’m the designated driver for all the time so I bring them places and
they told me they were on PrEP and that it was easy, they felt safer now.”
Most participants also considered themselves at risk of acquiring HIV and discussed engag-
ing in risky sexual behavior prior to incarceration. One participant stated: “You never really
know who you’re sleeping with. Or what you’re sleeping with at the time or what that person
has.” Another participant said: “There’s always the risk, like sometimes if I’m not having pro-
tected sex, if it’s just like one of those spur of the moment things it can happen any time, so.
Well like not, not always, sometimes like I might not have a condom or you just think that
everything will be fine and sometimes it’s not.”
In addition, several participants discussed addiction or drug use as an additional HIV risk
factor or drug use as a contributor to sexual risk behavior. One participant stated: “I could also
get in some bad stuff, sharing needles and stuff. Because I realized like I can relapse at any
point, and then when I’m using drugs if it’s not intravenously I’m usually still more promiscu-
ous, so like the risk of me getting HIV is just greater because I don’t care if I’m on drugs, I
guess. And I’ve been relapsing so much lately.” Another participant also talked about his drug
use in the community as a risk factor for engaging in risky sexual behavior: “I think I was for a
while. I was very much in the scene where I mean I did crystal, I did a lot of party drugs and I
was in a scene where sex was just everywhere.”
Correspondingly, most participants were also interested in taking PrEP. One participant
stated:
“I’d be kind of proud doing something that would help me. It’s doing me well, even though
I’m not doing the things its preventing me from doing. I’m helping myself if that time [to
engage in risky behavior] does happen to come. It’s like putting the salt on your porch
before it snows, so that the snow won’t ice up. It’s like preventing the slip and fall. Who
wants to slip and fall? I’m helping myself from messing myself up.”
Another participant said:
“I know that at the end of the day if there’s anything that can prevent it or help prevent it, I
say us as because whole like a family, you know what I mean, like the gay, transgender what-
ever like as a family we need to do whatever we can do to stop it, you know what I mean,
before it gets too deep.”
Overall, participants had limited knowledge about PrEP prior to completing the interview,
but the majority reported being at risk for HIV and acknowledged that their use of drugs con-
tributed to their risk for HIV. Participants had a positive view of PrEP and most were inter-
ested in learning more or taking it.
Preferences for PrEP provision
Participants were asked if they preferred to be prescribed PrEP prior to release from the
RIDOC or if they would like to be linked to a PrEP clinic in the community. The majority of
participants stated that they would like to receive a PrEP prescription and begin taking PrEP
just prior to release from the RIDOC. Many also preferred to have a prescription and drug in
hand (e.g. a 30-day PrEP pill pack) to take with them when they left. A participant stated: “[I’d
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like to get PrEP here] because I can get more information, first of all, I can be better with it,
and I can be more effective if using in case I have any relationship no matter what here or out-
side, I’ll already be careful.”
However, even though most expressed that they would prefer to be prescribed PrEP at
RIDOC, many stated that stigma and negative attitudes about, MSM, PrEP, and incarcerated
individuals could be a barrier. A participant said:
“I guess the only thing that the only thing that would probably cause a problem is that if
people knew that you were taking that medication and that that medication, it was strictly
being targeted for guys that were having sex with guys there might be backlash between you
know people that are homophobic.”
Another participant expressed a similar concern:
“Well, I think that the guards here don’t really take certain things seriously. You hear them
cracking jokes about med line, about giving out meds that aren’t really needed. I’d worry on
the administrative end that it wouldn’t be taken seriously enough as something that was
actually needed.”
Participants reported that it would be easier to obtain a prescription for PrEP prior to release
from incarceration. However, participants also voiced some concern about stigma associated with
using PrEP while incarcerated and worried that PrEP use would lead to assumptions about their
sexual orientation if other incarcerated individuals discovered they were taking it.
Barriers to PrEP uptake and adherence during community re-entry
Given that PrEP is not currently available at the RIDOC or most other correctional facilities in
the US, we asked participants what they thought might be barriers to PrEP uptake after release.
Barriers mentioned by participants were PrEP-related, including cost and partner or family
disapproval, and incarceration-related, including housing, transportation, the compounded
effect of multiple hardships during community re-entry, and fear of reincarceration.
Barriers associated with PrEP use. Many participants expressed concern over taking
PrEP. Most commonly cited were issues of cost and partner or family disapproval of PrEP use.
Cost While most participants were interested in taking PrEP, many wondered whether
access to health insurance was necessary to assuage the high cost of the medication. For
example:
“I mean just whether or not people’s health insurance would cover it, if that were to have an
effect on it cause for me. . .if it were to be an expensive drug for people that if they had to
pay for it without their health insurance helping them cover it then I think that that might
be a hindering issue in getting it.”
Disapproval of PrEP use Several participants reported that their partners or family might
not understand why they had decided to take PrEP. One participant stated:
“I have heard like about like ‘oh well that’s’ just for you know guys who want to hook up all
the time who don’t want to have to worry about getting AIDS or HIV’, like that’s not really
what it is, it’s a false, it’s a falsehood that you’re hearing, so I’d be afraid if like a family mem-
ber of mine were to ask somebody about it and they asked somebody who wasn’t
knowledgeable.”
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Another person also ruminated on why someone might not feel comfortable if their partner
knew they were taking PrEP:
“Let’s just say that you were a gay man with a partner and you are the type of person who
cheats. You might not want your partner to know that you’re on it because you don’t want
them to know that the reason you’re on it is because you’re having other sexual partners.”
Barriers associated with community re-entry. In addition to PrEP-related barriers,
many of the barriers discussed by participants were related to incarceration. Specific issues
mentioned by participants were lack of housing, transportation, and re-incarceration. In addi-
tion, several participants discussed how PrEP might necessarily be de-prioritized during com-
munity re-entry because compounding hardships that are exacerbated by incarceration must
be addressed first.
Transportation. Many participants discussed how lack of transportation was a concern
post-release that may affect PrEP uptake. When asked about barriers during community re-
entry, one participant said: “And transportation [is an issue] because I lost my car getting to
this craziness, like due to my charge. Like my car is under investigation, so that’s another thing
that I’m really worried about.” Another participant stated: “A bus, a car, or some way to get
there. Provided by anybody ‘cause I have a problem, my license run out so I can’t drive.” Simi-
larly, past research has identified lack of access to transportation as a barrier for recently incar-
cerated individuals to receiving HIV care.
Housing. Housing is often a concern for those leaving correctional institutions. Com-
ments from participants mirrored these previous findings as most participants expressed wor-
ries about finding housing. For instance, a participant reported: “Well pretty much [I have]
placement issues being that I’m not from Rhode Island.” Another stated: “I’m trying to find a
place to live now. Cause I got nowhere.”
Compounded impact of multiple hardships during community re-entry and de-prioriti-
zation of PrEP. Many participants anticipated facing compounding hardships during com-
munity re-entry. Knowing that they would have many responsibilities and little resources after
release, they wondered if PrEP would be a priority. A participant stated:
“When you go home you have so much to do. You have to go get your ID, and then you
have to go back to welfare to get food stamps. You have so much different stuff you have to
do for that first couple of days that you’re not really going to be thinking about I’ve got to
go to the doctor’s [office] right away to get my PrEP. You have to go home and handle
every other thing first.”
This same participant goes on to say:
“I mean every man goes through a couple of these, you know who’s going to be out there
on the outside, who’s doing what, whether your friends are going to stick by you or not,
whether they are going to leave you, and then there’s other worries like for those of us who
have lost our apartments, where am I going to stay, you know all that stuff. That first day is
kind of crucial to figure out things, and then if you don’t have anywhere to stay and you’re
living with a friend temporarily you have that worry about getting your own place together,
getting stuff together, security deposit, first month’s rent again. So, it’s a little bit of a mess.
Another participant discussed how PrEP may not be a priority during community re-entry:
“Often times when a lot of us get out on the street we forget to do research, or we have so
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much going on that we don’t, or too much on our plates that it would probably be gone from
my mind by the time I got off of it.”
Finally, another participant stated that while incarcerated people might prioritize PrEP,
during post-release this may not be possible: “They [people who are incarcerated] have time to
think you know and you want to participate in this and you want to do this, this, that, and you
get that information, but people on the street don’t have time for that. They don’t want that.
You know they, they want something that they give you and stuff like that. They don’t want to
be part of that stuff.” In this quote, the participant is expressing the idea that while incarcerated
individuals may have more time on their hands and would get involved in both research stud-
ies and engaging in other activities (like PrEP) but would not give these activities the same con-
sideration in the community due to competing responsibilities.
Participants reported several competing hardships they were likely to experience post-
release that may make getting information about PrEP and obtaining a prescription difficult.
In addition, individuals acknowledged that if these hardships were not addressed they would
likely be re-incarcerated: “If I don’t have another place to live I’m coming back. It’s just like
you know the open-door policy is like a revolving door, you keep on going in and out, in and
out, in and out.”
Discussion
In this study, we evaluated knowledge, interest, and barriers to PrEP among CJ-involved
MSM. Participant responses highlighted the ways in which PrEP can benefit those who are
currently or recently CJ-involved but also illustrated the unique challenges to PrEP provision
while incarcerated and uptake during community re-entry. The majority of participants
expressed high interest in PrEP despite initial low knowledge, and many participants perceived
themselves at high risk for acquiring HIV, citing overlapping sexual and substance use risk
behaviors. While most participants expressed interest in beginning PrEP prior to release, they
also emphasized how issues related to stigma might be a challenge to program implementation
and PrEP uptake. Barriers to PrEP during community re-entry included lack of transportation,
housing instability, cost, disapproval by peers and family, fears of re-incarceration and the de-
prioritization of PrEP due to compounding hardships in the community.
Although no existing studies to our knowledge have focused on PrEP uptake among MSM
with recent incarceration, our findings corroborate existing research related to both issues that
are 1) challenges during community re-entry and 2) barriers to PrEP uptake and adherence in
general. Participants reported housing instability and lack of transportation as significant bar-
riers to PrEP uptake and adherence. The relationship between community re-entry and hous-
ing instability has been well documented [36–39]. Similarly, past research has identified lack of
access to transportation as a barrier for recently incarcerated individuals to receiving HIV care
[40–42]. Similarly, several PrEP uptake studies have identified cost and partner or family dis-
approval as barriers [43–46]. These issues are likely to present significant barriers to PrEP
uptake and adherence among recently incarcerated MSM that may compound existing behav-
ioral risk factors. Strategies to address and overcome these concerns are needed to implement
effective PrEP programs in this population.
A unique finding of this study is the “de-prioritization” of PrEP post-release due to the
overwhelming nature of multiple hardships that are present during community re-entry.
Other studies have found that individuals may experience competing needs and that various
multi-level factors may present barriers to engagement and retention in HIV care [47–50]. In
our study, many participants pointed out that while they were interested in PrEP, they would
have many practical issues to address that would come first. This highlights the need to
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consider establishing PrEP access prior to release either through referral (as a part of discharge
services) to a PrEP clinic or, preferably, prescribing PrEP shortly before discharge. Prior to
release individuals should have access to medical discharge planning services that ensure at-
risk MSM can engage in comprehensive care that spans the PrEP continuum (uptake, adher-
ence, and retention in care). Peer navigator programs that work with correctional staff to con-
nect those at risk to PrEP programs in the community post-release may also be particularly
useful. The use of peers has been a successful strategy for linking HIV positive individuals to
care after release [51]. In addition, case management that links people to treatment for sub-
stance use and mental health may also aid in the alleviation of other community re-entry ori-
ented burdens, and, thus, prevent incarceration-related barriers may prohibit PrEP uptake. In
addition, PrEP education prior to release in the form of brief education classes, distribution of
informational brochures, or one-on-one PrEP sessions with a medical professional may
assuage concerns related to cost, as participants can learn about patient assistance programs,
and develop strategies to deal with PrEP-related stigma.
Finally, it is worth underscoring that while the HIV risk inclusion criteria for this study was
self-identifying as gay, bisexual or MSM, many participants found themselves at the intersec-
tion of risky drug use and sexual behavior. Therefore, future interventions targeting CJ-
involved MSM should consider strategies that address sexual risk taking and substance use
during community re-entry. This could include partnering PrEP interventions with medica-
tion assisted treatment programs that provide access to methadone, buprenorphine, or nal-
trexone in addition to HIV prevention services.
Limitations
This study was conducted in a single state unified jail and prison system wherein a larger pro-
portion of incarcerated individuals are White, which is very different from other states and
may limit the generalization of our results. These findings are meant to only provide a forma-
tive understanding of PrEP among MSM in RI rather than be generalizable to all incarcerated
MSM. However, future research should explore PrEP interest and attitudes among racial and
ethnic minorities who are incarcerated. In addition, being included as a participant relied
upon individuals’ self-report of being gay, bisexual or MSM, which may have many limitations.
Individuals may have been unwilling to disclose that they were a MSM at the RIDOC due to
anticipated stigma. Therefore, our sample is biased to only include those who felt comfortable
disclosing. Finally, the current study does not explore the use of PrEP among other high risk
incarcerated populations (e.g. those engaging in transactional sex or people who inject drugs).
Conclusion
The current study is among the first to report on PrEP knowledge, interest, and barriers
among CJ-involved MSM. Our results suggest that CJ-involved MSM are at the intersection of
overlapping HIV risk factors, and that although knowledge of PrEP was low, significant inter-
est exists. Barriers to PrEP include common community re-entry obstacles such as housing
instability and lack of access to transportation and, general PrEP-related challenges such as
cost and stigma. In addition, the multiple hardships often experienced during community re-
entry compound and result in a de-prioritization of PrEP. Therefore, according to participant’s
preference, future interventions should facilitate access to PrEP (either via referral or prescrib-
ing prior to discharge) before release and address barriers illuminated in this study.
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